Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.

Detalles Bibliográficos
Publicado en:Strahlentherapie und Onkologie Vol. 188; no. 3; pp. 216 - 226
Autores principales: Lorentini S, Amichetti M, Spiazzi L, Tonoli S, Magrini SM, Fellin F, Schwarz M, Lorentini, S, Amichetti, M, Spiazzi, L, Tonoli, S, Magrini, S M, Fellin, F, Schwarz, M
Formato: clinical trial research Journal Article
Publicado: Springer Nature Mar2012
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104444017&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104444017
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01797158
        NZE
      jtl: Strahlentherapie und Onkologie
      issn: 01797158
      maglogo: N
    pubinfo:
      dt: Mar2012
      vid: 188
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        104444017
        104444017
        NLM22318326
        2011752738
        10.1007/s00066-011-0038-3
        NLM22318326
        104444017
      ppf: 216
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.
      aug:
        au:
          Lorentini S
          Amichetti M
          Spiazzi L
          Tonoli S
          Magrini SM
          Fellin F
          Schwarz M
          Lorentini, S
          Amichetti, M
          Spiazzi, L
          Tonoli, S
          Magrini, S M
          Fellin, F
          Schwarz, M
        affil: ATreP - Agenzia Provinciale per la Protonterapia, Via F.lli Perini, 181, 38122, Trento, Italy
      sug:
        subj:
          Mesothelioma, Malignant Radiotherapy
          Pleural Neoplasms Radiotherapy
          Radiotherapy, Conformal Methods
          Aged
          Female
          Human
          Male
          Middle Age
          Therapeutics
          Body Regions
          Radiation Dosage
          Radiotherapy, Computer-Assisted
          Radiotherapy, Adjuvant
          Radiotherapy, Conformal Adverse Effects
          Clinical Trials
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N